Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate Nasal Spray for Sleep-disordered Breathing in PAR
NCT00359216Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- May 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of mometasone furoate nasal spray in perennial allergic rhinitis (PAR), sleep disordered breathing (SDB), sponsored by Organon & Co.. Started May 2006; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
perennial allergic rhinitis (PAR)sleep disordered breathing (SDB)
Beyond the preview
Go deeper on NCT00359216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359216.